USA - New York Stock Exchange - NYSE:TMO - US8835561023 - Common Stock
The current stock price of TMO is 606.5 USD. In the past month the price increased by 7.71%. In the past year, price increased by 11.84%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DHR | DANAHER CORP | 30.48 | 165.99B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 200.24 | 60.85B | ||
| A | AGILENT TECHNOLOGIES INC | 26.12 | 41.32B | ||
| IQV | IQVIA HOLDINGS INC | 20.91 | 41.42B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.02 | 29.93B | ||
| WAT | WATERS CORP | 31.23 | 23.61B | ||
| ILMN | ILLUMINA INC | 33.45 | 22.28B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.93 | 19.80B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.96 | 16.90B | ||
| TEM | TEMPUS AI INC | N/A | 12.16B | ||
| RVTY | REVVITY INC | 21.23 | 11.53B | ||
| CRL | CHARLES RIVER LABORATORIES | 20.43 | 10.61B |
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
THERMO FISHER SCIENTIFIC INC
168 Third Avenue
Waltham MASSACHUSETTS 02451 US
CEO: Marc N. Casper
Employees: 125000
Phone: 17816221000
Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.
The current stock price of TMO is 606.5 USD. The price decreased by -1.73% in the last trading session.
THERMO FISHER SCIENTIFIC INC (TMO) has a dividend yield of 0.3%. The yearly dividend amount is currently 1.52.
TMO has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
31 analysts have analysed TMO and the average price target is 646.25 USD. This implies a price increase of 6.55% is expected in the next year compared to the current price of 606.5.
The PE ratio for THERMO FISHER SCIENTIFIC INC (TMO) is 27.08. This is based on the reported non-GAAP earnings per share of 22.4 and the current share price of 606.5 USD.
THERMO FISHER SCIENTIFIC INC (TMO) will report earnings on 2026-01-29, after the market close.
ChartMill assigns a technical rating of 8 / 10 to TMO. When comparing the yearly performance of all stocks, TMO is one of the better performing stocks in the market, outperforming 71.08% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to TMO. While TMO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
Over the last trailing twelve months TMO reported a non-GAAP Earnings per Share(EPS) of 22.4. The EPS increased by 4.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.02% | ||
| ROA | 6.38% | ||
| ROE | 12.88% | ||
| Debt/Equity | 0.62 |
31 analysts have analysed TMO and the average price target is 646.25 USD. This implies a price increase of 6.55% is expected in the next year compared to the current price of 606.5.
For the next year, analysts expect an EPS growth of 5.08% and a revenue growth 3.54% for TMO